Navigation

Constipation (women) - prucalopride

Prucalopride for the treatment of chronic constipation in women

Status: History
Expected date of issue: December 2010
Referral date: September 2009
Process: STA
Notes:

Scoped within Batch 8

Topic area:
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Raphael Yugi
Communications manager: Shalu Kanal
Project manager: Lori Farrar
Assessment Group / Evidence Review Group: West Midlands Health Technology Assessment Collaboration (WMHTAC)
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 29 March 2010
1st appraisal committee meeting: 08 July 2010
2nd appraisal committee meeting 08 September 2010
Top


 

Consultees and commentators

Consultees

Commentators (no right of appeal)

Manufacturers/sponsors

  • Movetis (prucalopride)

Patient/carer groups

  • PromoCon 

Professional groups

  • Association of Continence Advice
  • British Society of Gastroenterology
  • Royal College of Nursing
  • Royal College of Physicians

Others

  • Department of Health
  • NHS Greenwich
  • Welsh Assembly Government

General

  • British National Formulary
  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland

Comparator manufacturers

  • Napp Pharmaceuticals (dantron)
  • Norgine Pharmaceuticals (sterculia/frangula, macrogol, docusate sodium enema)
  • Typharm (docusate)
  • Winthrop Pharmaceuticals UK (dantron/docusate sodium)

Relevant research groups

  • None

Evidence Review Group

  • National Institute for Health Research Health Technology Assessment Programme
  • West Midlands Health Technology Assessment Collaboration (WMHTAC)

Associated Guideline groups

  • None

Associated Public Health groups

  • None

Top


 

Key documents

This page was last updated: 14 December 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.